Pharma News

Join WhatsApp Channel 

Crack GPAT — Prepare for GPAT Online 

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • IPC Urges Medical Device Companies to Strengthen Adverse Event Reporting Under MvPI
    3 February 2026

    IPC Urges Medical Device Companies to Strengthen Adverse Event Reporting Under MvPI

    The Indian Pharmacopoeia Commission (IPC), under the Ministry of Health and Family Welfare, has urged all Medical Device Marketing Authorisation Holders (MAHs) to ensure strict compliance with adverse event reporting under the Materiovigilance Programme of India (MvPI), stressing that timely reporting is critical to patient safety and effective regulatory oversight.
  • 2 February 2026
    Lupin Strengthens U.S. Oncology Portfolio with Launch of Dasatinib Tablets
    Lupin Limited has launched Dasatinib Tablets in the United States, marking another significant step in expanding its oncology portfolio in the world’s largest pharmaceutical market.
  • 2 February 2026
    Budget Boost to Make India a Global Biopharma Hub
    In a major push for India’s pharmaceutical and biopharmaceutical sectors, the Union Budget 2026-27, presented by Finance Minister Smt. Nirmala Sitharaman in Parliament today, announced comprehensive initiatives aimed at strengthening domestic capacity, fostering innovation and positioning India as a global biomanufacturing leader.
  • 31 January 2026
    Wearable Hydrogel Breakthrough for Real-Time Cardio & Respiration Tracking
    Scientists have developed an advanced MXene-based wearable hydrogel sensor capable of continuous heart rate and respiratory monitoring under extreme conditions such as high heat, humidity and vigorous exercise.
  • 31 January 2026
    AstraZeneca taps CSPC to supercharge Obesity & Type 2 Diabetes Pipeline
    AstraZeneca has entered a major collaboration with China’s CSPC Pharmaceuticals to advance the development of next-generation therapies targeting obesity and type 2 diabetes.
  • 30 January 2026
    Assam Govt Upholds Validity of Pharmacy Council Election, Council Constituted

    The Government of Assam has formally upheld the validity of the Assam Pharmacy Council (APC) election held in February 2024 and confirmed the constitution of the Council, bringing an end to all disputes related to the election process.

  • 30 January 2026
    Roche Reports Strong 2025 Performance, Lifts Outlook as Pharma Sales Drive Growth
    Swiss pharmaceutical and diagnostics giant Roche Group reported a strong financial performance for full-year 2025, with group sales rising 7 % at constant exchange rates, driven by solid demand for both medicines and diagnostic solutions, the company said in a media release on Thursday.
  • 29 January 2026
    CGHS notifies Senior Pharmacist RRs, grants Group ‘B’ Status amid dissent
    Central Government Health Scheme, CGHS, Ministry of Health and Family Welfare, marking a major structural shift in the pharmacy cadre. For the first time, CGHS pharmacists are eligible for promotion to a Group B, Non-Gazetted post.
  • 29 January 2026
    Astrazeneca plans USD 15b investment in China through 2030 to boost R&D, manufacturing

    British pharmaceutical firm AstraZeneca PLC announced on Thursday it will commit usd 15 billion (about ₹1.2 lakh crore) to expand research, development and manufacturing operations in China through 2030, underscoring the country’s growing importance in global drug innovation and production.

    The investment, detailed in a company press release, aims to bolster AstraZeneca’s capabilities across the entire drug value chain from discovery and clinical development to large-scale manufacturing, particularly in cell therapies and radioconjugates, two areas of rapid scientific advance.

  • 29 January 2026
    New Alzheimer Europe Report Projects 64% Increase in Dementia Across Europe by 2050

    Alzheimer Europe today released a new report titled “The Prevalence of Dementia in Europe 2025”, projecting a substantial rise in the number of people living with dementia across the continent over the next quarter-century. The report updates prevalence figures using recent community-based studies and United Nations population projections for 2025 and 2050.

Subscribe to Pharma News